John Lee
Molecular Biology · with Chung · 2010
A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Molecular Biology — 45 citations into it; #17,582 of 17,773 by trust here, #13,891 by citations
- Cancer Research — 28 citations into it; #1,756 of 1,780 by trust here, #1,528 by citations
Whom John Lee trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts John Lee overall
Papers from John Lee's perspective
Ordered by how strongly the researchers John Lee trusts endorse each paper. Same corpus, a different order for every researcher.
- Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis (Nature Cell Biology)
- Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. (Cancer Cell)
- The biology of VEGF and its receptors (Nature Medicine)
- Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. (Cell)
- Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells (Nature Medicine)
- Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system (Nature reviews. Molecular cell biology)
- Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. (Blood)
- The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies (Journal of Pathology)
- Lack of Pericytes Leads to Endothelial Hyperplasia and Abnormal Vascular Morphogenesis (Journal of Cell Biology)
- Myeloid-derived-suppressor cells as regulators of the immune system (Nature reviews. Immunology)
Their papers
- Targeting the tumour vasculature: insights from physiological angiogenesis (2010) — 752 citations